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Pemphigus vulgaris is an autoimmune blistering dis-
ease of the skin and mucous membranes that is
caused by anti-desmoglein 3 IgG autoantibodies.
Recently, we generated an active disease mouse
model for pemphigus vulgaris by adoptive transfer of
splenocytes from immunized desmoglein 3±/± mice
to Rag2±/± mice. In this study, we performed immu-
nologic and histopathologic studies using this pem-
phigus vulgaris model in mice and compared the
gross and microscopic phenotypes of pemphigus vul-
garis model mice and desmoglein 3±/± mice.
Pemphigus vulgaris model mice showed strong in vivo
IgG, and weak IgA deposition on keratinocyte cell
surfaces in strati®ed squamous epithelia, and pro-
duced circulating anti-desmoglein 3 IgG antibodies
without apparent cross-reactivity to desmoglein 1,
in enzyme-linked immunosorbent assays. The pre-
dominant IgG subclass was IgG1. Pemphigus vul-
garis model mice and desmoglein 3±/± mice were
almost indistinguishable in terms of both gross and
microscopic ®ndings. Both types of mice showed
suprabasilar acantholysis in the strati®ed squamous
epithelia, including the oral mucous membranes and
traumatized skin around the snout or paws; how-
ever, some pemphigus vulgaris model mice demon-
strated a more severe phenotype than desmoglein
3±/± mice. The esophagus and forestomach were
affected in some pemphigus vulgaris model mice,
but not in desmoglein 3±/± mice. Furthermore, eosi-
nophilic spongiosis, which is found in early pemphi-
gus vulgaris lesions in patients, was observed in
pemphigus vulgaris model mice but not in desmo-
glein 3±/± mice. Pemphigus vulgaris model mice
re¯ect several of the histopathologic and immunolo-
gic features seen in pemphigus vulgaris patients, and
provide a valuable tool to investigate the pathophy-
siologic mechanisms of pemphigus vulgaris. Key
words: autoimmunity/eosinophilic spongiosis/experimental
model/knockout mouse/pemphigus. J Invest Dermatol
118:199±204, 2002
P
emphigus vulgaris (PV) is an autoimmune blistering
disease of the skin and mucous membranes that is
characterized clinically by ¯accid blisters and erosions,
and histopathologically by the loss of keratinocyte
cell±cell adhesion, resulting in ``acantholysis'' (Stanley,
1998). The autoimmune target of PV has been identi®ed as
desmoglein 3 (Dsg3), a transmembrane desmosomal component
that belongs to the cadherin supergene family (Amagai et al,
1991, 1994). Accumulated evidence indicates a pathogenic role
for anti-Dsg3 IgG autoantibodies in the blister formation that is
characteristic of PV (Schiltz and Michel, 1976; Anhalt et al,
1982; Hashimoto et al, 1983; Merlob et al, 1986; Amagai et al,
1992; Stanley, 1993; Amagai, 1995). Several attempts have been
made to develop animal models to help clarify the pathophy-
siologic mechanism of PV (Anhalt et al, 1982; Juhasz et al,
1993; Fan et al, 1999).
A passive transfer model using neonatal mice was developed
(Anhalt et al, 1982). In this model, highly concentrated IgG from
the sera of PV patients was injected into neonatal mice and 8±24 h
later the mice developed blisters and erosions with the typical
pemphigus histology. Subsequently, it was demonstrated that the
Fab fragments of IgG puri®ed from PV patients induce similar
blistering in neonatal mice (Rock et al, 1990; MascaroÂ et al, 1997).
Thus, this model provides solid evidence that IgG from patients'
sera plays a pathogenic role in inducing blistering, without the
involvement of cellular immune responses or complement. This
model is still widely used to study the pathogenic role of IgG;
however, it re¯ects only the acute phase (within 24 h) of blister
formation. In addition, the blisters are induced in neonatal mice,
but not in adult mice. Therefore, the phenotypes of adult mice
with PV could not be explored.
In 1997, Dsg3-knockout mice were produced by genetic
disruption of DSG3 (Koch et al, 1997). Dsg3±/± mice showed
extensive erosions in the oral mucous membranes with suprabasilar
acantholysis, which resulted in weight loss due to insuf®cient food
intake. Erosive lesions were also found in traumatized skin. These
®ndings clearly demonstrated the important in vivo role of Dsg3 in
the cell±cell adhesion of keratinocytes. In addition, Dsg3±/± mice
demonstrated telogen hair loss, providing the ®rst cutaneous
manifestation of Dsg3 dysfunction in adult mice (Koch et al, 1998).
These ®ndings also suggested that anti-Dsg3 autoantibodies directly
interfered with the adhesive function of Dsg3 to cause blisters;
however, no immunologic components were involved in deter-
mining the phenotype of the Dsg3±/± mice.
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An active disease mouse model for PV was generated by a novel
approach, using Dsg3±/± mice that could not be tolerized against
Dsg3 (Amagai et al, 2000). After the Dsg3±/± mice were immunized
with mouse recombinant Dsg3 (rDsg3), splenocytes from the
immunized mice were transferred into Rag2±/± mice that expressed
Dsg3. T and B cells from Dsg3±/± mice were stimulated with
endogenous Dsg3 in the recipient mice, and anti-Dsg3 IgG was
stably produced for over 6 mo. The anti-Dsg3 IgG bound to Dsg3
in vivo and caused blisters and erosions in the oral mucous
membranes as well as in traumatized skin with suprabasilar
acantholysis. The recipient mice also showed telogen hair loss.
In this study, we characterized PV model mice both immuno-
logically and histopathologically and compared the gross and
microscopic phenotypes of PV model and Dsg3±/± mice. We
determined the speci®city and the IgG subclass of antibodies raised
in the PV model mice. We performed detailed histopathologic
investigations of PV model and Dsg3±/± mice and compared the
distribution of affected sites and the severity of phenotype.
Moreover, we determined whether PV model mice showed
eosinophilic spongiosis, which is a characteristic histologic ®nding
in the early lesions of PV patients (Emmerson and Wilson Jones,
1968; Knight et al, 1976; Pearson et al, 1980).
MATERIALS AND METHODS
Mice Dsg3±/± mice were obtained by mating male Dsg3±/± and female
Dsg3+/± mice (The Jackson Laboratory, Bar Harbor, ME). These mice
have a mixed genetic background of 129/SV (H-2b) and C57BL/6J
(H-2b). Rag2±/± mice that had been backcrossed to B6.SJL-Ptprca mice
for 10 generations (Schulz et al, 1996) were purchased from Taconic
Farms (Germantown, NY).
PV model mice PV model mice were prepared as previously reported
(Amagai et al, 2000). Brie¯y, Dsg3±/± mice were primed once with
10 mg of puri®ed mouse rDsg3 in complete Freund's adjuvant, then
immunized twice with incomplete Freund's adjuvant and twice without
adjuvant. Antibody production was examined regularly by enzyme-
linked immunosorbent assay (ELISA) using mouse rDsg3. Splenocytes
were isolated from Dsg3±/± mice after immunization and injected
intravenously into Rag2±/± mice.
Direct immuno¯uorescence Five PV model mice were killed and
biopsy specimens were taken from the snout, palate, esophagus, and
forestomach, and embedded in OCT compound (Sakura Finetechnical,
Tokyo, Japan) for cryostat sectioning. For standard direct
immuno¯uorescence studies, each section was incubated with a 100-fold
dilution of ¯uorescein isothiocyanate-rabbit anti-mouse IgG antibody
(Zymed Laboratories, San Francisco, CA), ¯uorescein isothiocyanate-goat
anti-mouse IgM, IgA, C3 (Cappel Product, Aurora, OH) and ®brinogen
IgG fractions (Nordic Immunological Laboratories, Tilburg, the
Netherlands). For subclass determinations, the sections were ®rst
incubated with a 50-fold dilution of rat anti-mouse IgG1, IgG2a, IgG2b,
and IgG3 monoclonal antibodies (PharMingen, San Diego, CA) and,
after washing in phosphate-buffered saline, stained secondarily with a
1000-fold dilution of Alexa Fluor 488-goat anti-rat IgG antibody
(Molecular Probes, Eugene, OR). All of the sections were examined
using a ¯uorescence microscope (Eclipse E800, Nikon, Tokyo, Japan).
ELISA ELISA using recombinant mouse Dsg1 and Dsg3 were
performed, essentially as previously described for human Dsg1 and Dsg3
ELISA (Ishii et al, 1997; Amagai et al, 1999). First, the ELISA plate was
coated with 2.5 mg per ml of mouse rDsg1 and rDsg3 expressing the
entire extracellular domain (Amagai et al, 2000). For anti-Dsg3 IgG, IgA,
IgM, and anti-Dsg1 IgG ELISA, 5000-fold dilutions of PV mouse serum
were incubated for 1 h on individual ELISA plates. After washing, the
plates were incubated with 5000-fold dilutions of peroxidase-labeled goat
anti-mouse IgG, IgA and IgM polyclonal antibodies (Zymed
Laboratories) for 1 h. The plates were then washed, and color
development was performed using a solution containing equal amounts
of tetramethylbenzidine and hydrogen peroxide (Medical Biological
Laboratories, Nagano, Japan) for 30 min; the reaction was stopped by
adding 100 ml of 4 M H2SO4. The optical density (OD) of each sample
was measured at 450 nm in a microplate reader (Bio-Rad Laboratories,
Hercules, CA).
For the IgG subclass ELISA, 1000-fold dilutions of sera from PV
model mice were incubated for 45 min in plates that had been coated
with mouse rDsg3. After washing, the plates were incubated with a
1000-fold dilution of rat anti-mouse IgG1, IgG2a, IgG2b, and IgG3
monoclonal antibodies (PharMingen, San Diego, CA) for 45 min, and
washed once more. All of the plates were incubated with a 2500-fold
dilution of peroxidase-labeled goat anti-rat IgG polyclonal antibody for
45 min, washed, developed and analyzed as described above. Thirty-one
PV model mouse sera and 10 normal mouse sera were analyzed for
subclass with anti-Dsg3 IgG, IgA, and IgM, or anti-Dsg1 IgG. For the
IgG subclass ELISA, 20 PV model mouse sera and 10 normal control
sera were analyzed for each individual subclass.
We calculated the mean and SD for each subclass ELISA using the
OD values of normal controls. Based on the value obtained from the
formula: mean + 3 SD, we set cut-off values of 0.10 for anti-Dsg1 IgG
ELISA, 0.027 for anti-Dsg3 IgG, IgA, and IgM ELISA, and 0.062 for
IgG subclass ELISA.
Histopathologic analysis We examined 15 PV model mice and 15
Dsg3±/± mice and a normal C57BL/6J mouse. The entire animal skin
was cut into small strips of about 1.5 mm by 20 mm for extensive
histopathologic analysis. These strips were arranged in continuous order
in plastic cassettes in order to preserve the original orientation. The
head, limbs, and tail were decalci®ed and cut into serial sections at
1.5 mm spacings. The esophagus, forestomach, stomach, small and large
intestine, lung, liver, heart, and kidney were taken separately and serial
sections were prepared. All these sections were stained with hematoxylin
and eosin and examined by light microscopy. The distribution of
suprabasilar acantholysis, erosion, and spongiosis was noted. A lesion was
de®ned as an affected site in cases where a microscopic lesion with
suprabasilar acantholysis was spatially separated from other lesions by
normal epidermis. The number of affected sites per individual mouse was
counted for each mouse group.
Eosinophil staining To assess the presence of eosinophilic spongiosis,
52 sites in 19 sections from nine PV model mice and 40 sites in 16
sections from seven Dsg3±/± mice, all of which had apparent spongiosis,
were selected and stained with Chromotrope 2R (Lendrum, 1944) and
hematoxylin. In this study, eosinophilic spongiosis was diagnosed when
Figure 1. Predominant IgG1 deposition on keratinocyte surfaces
in PV model mice in vivo. (a) Strong IgG and very weak IgA
deposition was observed on the surfaces of keratinocytes of the palate of
PV model mice. F, ®brinogen. (b) IgG1 was predominantly observed in
the intercellular space. IgG2a and IgG2b were weakly detected and no
apparent IgG3 deposition was observed. Scale bar: 50 mm.
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more than three exocytic eosinophils were observed in the intercellular
space under 3 400 magni®cation.
RESULTS
Predominant IgG1 subclass for anti-Dsg3-speci®c IgG
autoantibodies in the PV model mouse A direct
immuno¯uorescence study was performed to delineate both the
class and subclass of predominant immunoglobulins that were
deposited in the intercellular space in vivo. Immunostaining of the
PV model mouse palate showed strong IgG deposition on
keratinocyte cell surfaces (Fig 1a). Although weak deposition of
IgA was also detected in the intercellular space, the staining pattern
tended to be granular. Broad C3 deposition was observed around
the basement membrane zone, probably due to local in¯ammation.
No depositions of IgM or ®brinogen were observed. IgG subclass
staining revealed that IgG1 was predominant, with distinct linear
deposition patterns on keratinocyte surfaces (Fig 1b). Weak
deposition of IgG2a and IgG2b was also observed in the
intercellular space, whereas no IgG3 deposition was detected.
ELISA using mouse rDsg1 and rDsg3 were used to determine the
immunoglobulin class of circulating autoantibodies. All 31 PV
model mice sera were positive for anti-Dsg3 IgG, but negative for
anti-Dsg1 IgG (Fig 2a). Most of the sera were negative for anti-
Dsg3 IgA or anti-Dsg3 IgM, although three of 31 and one of 31
sera slightly exceeded the cut-off values for anti-Dsg3 IgA and anti-
Dsg3 IgM, respectively.
An IgG subclass ELISA was performed with mouse rDsg3 to
investigate further the subclasses of circulating anti-Dsg3 IgG in PV
model mice (Fig 2b). All 20 sera were positive for IgG1, with a
mean OD value of 0.59, whereas 12 of 20 sera were positive for
IgG2a and Ig2b with lower mean OD values of 0.097 and 0.090,
respectively. No sera were positive for IgG3 (mean OD of 0.009).
Some PV model mice have a more severe phenotype than
Dsg3±/± mice PV model mice weighed less and had patchy hair
loss compared with normal mice (Amagai et al, 2000). The weight
loss was probably because oral erosions, arising from the presence of
anti-Dsg3 IgG, discouraged food intake. The patchy baldness was
due to telogen hair loss (Koch et al, 1997; Amagai et al, 2000).
Encrusted erosions on the traumatized skin around snouts, eyes,
ears, paws, and tails were also observed in PV model mice (Fig 3a).
These characteristics were also observed in Dsg3±/± mice (Fig 3b);
however, some PV model mice showed heavily encrusted erosions
on the paws and elongated front teeth (Fig 3c). It was likely that
these mice were unable to gnaw solid food because of painful oral
erosions and this resulted in tooth elongation. Severe defects such as
these were rarely observed among Dsg3±/± mice (Fig 3d).
Suprabasilar acantholysis is observed in similar distribution
in both mice, except in esophagus and forestomach The
distribution of suprabasilar acantholysis, a typical histologic ®nding
of PV, was intensively examined in serial sections of the skin and
mucous membranes of PV model and Dsg3±/± mice (n = 15 for
each mouse group) (Table I). In general, the distribution was
similar in PV model and Dsg3±/± mice. Both types of mouse had
skin lesions on the snout, eyelid, ear, trunk, paw, and tail, i.e., areas
that are normally traumatized by scratching or constant physical
pressure (Fig 4a±f). Both PV model and Dsg3±/± mice showed
lesions in the squamous mucosae of the tongue, buccal mucosa,
palate, and larynx (Fig 4g, h); however, some PV model mice also
Figure 2. Circulating IgG1 against mouse Dsg3 predominates in sera obtained from PV model mice. (a) All 31 PV model mice sera were
positive for anti-Dsg3 IgG, whereas all were negative for anti-Dsg1 IgG. Three and one sera were slightly positive for anti-Dsg3 IgA and IgM,
respectively. (b) All 20 PV model mice sera showed positive in IgG1 ELISA, whereas 12 sera were positive for IgG2a and IgG2b. No sera were
positive for IgG3. Bars indicate the cut-off values determined for individual ELISA.
Figure 3. Gross phenotypes of PV model and Dsg3±/± mice.
Compared with the wild-type B6 mouse (a, right), PV model mice (a,
left) showed patchy telogen hair loss and weight loss. Dsg3±/± mice also
showed patchy telogen hair loss and weight loss (b), similar in extent to
the PV model mice. Some PV model mice showed crust-covered severe
erosions on the paws, and elongated front teeth (c), whereas Dsg3±/±
mice rarely showed these changes (d). Scale bar: 2 cm.
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had lesions in the esophagus and squamocolumnar junction of the
forestomach (Fig 4i, j). Lesions in these areas have not been seen in
Dsg3±/± mice, as described in the original report (Koch et al, 1997).
Dense in¯ammatory in®ltrations of lymphocytes and neutrophils,
probably as a result of secondary in¯ammation after barrier
disruption, were noted in both PV model and Dsg3±/± mice
(Fig 4a±d). Early lesions were not accompanied by in¯ammatory
cell in®ltrates. No pathologic abnormalities were observed in the
lungs, hearts, kidneys, livers, or intestines of any mice (Table I).
PV model mice show a broader variety of lesions than
Dsg3±/± mice To compare the extent of lesion formation in PV
model and Dsg3±/± mice in a quantitative fashion, the number of
sites with suprabasilar acantholysis in histology was counted for
each of 15 PV model and Dsg3±/± mice (Fig 5). In this assay, hair
follicle involvement was excluded because it was hair-cycle
dependent. The Dsg3±/± mouse group showed one to six affected
sites per mouse, with a mean value of 3.9 6 1.8. In contrast, the
PV model mouse group showed three to 11 affected sites per
mouse, with a mean value of 6.6 6 3.1. The PV model mice had
more affected sites than the Dsg3±/± mice (p = 0.02, Mann±
Whitney analysis). Among the mice tested, seven PV model mice
had more lesions than any of the Dsg3±/± mice. Therefore, PV
model mice exhibited broader variation in the number of lesions
than Dsg3±/± mice and some PV model mice had more severe
lesions.
Eosinophilic spongiosis in PV model mice PV patients
display spongiosis accompanied by eosinophilic cell in®ltrations in
early erythematous lesions. This phenomenon is known as
``eosinophilic spongiosis'' (Emmerson and Wilson Jones, 1968;
Knight et al, 1976; Pearson et al, 1980). To evaluate whether the
human histologic changes were reproduced in the PV model
mouse, we stained spongiotic sections of both PV model and
Dsg3±/± mice with Chromotrope 2R. We de®ned eosinophilic
spongiosis as spongiosis with more than three exocytic eosinophils
in the intercellular space. On this basis, eosinophilic spongiosis was
observed at 12 of 52 sites with spongiotic change in 19 sections
from PV model mice (n = 9) (Fig 6a). In contrast, no eosinophilic
spongiosis was found at 40 spongiotic sites in 16 sections from
Dsg3±/± mice (n = 7) (Fig 6b), although occasional dermal
eosinophil in®ltrations were observed in a few sections.
DISCUSSION
In this study, we immunologically and histopathologically
characterized novel PV model mice and compared the gross and
microscopic phenotypes of PV model and Dsg3±/± mice. The
predominant subclass in vivo of both bound and circulating anti-
Dsg3 antibodies was IgG1. In addition to IgG1, weak anti-Dsg3
IgG2a and IgG2b were also detected, both in vivo and in vitro.
Although there were weak granular deposits of IgA in the mouse
skin, the signi®cance of this ®nding is unclear, as we did not detect
any signi®cant circulating IgA against Dsg3 by ELISA. Thus, the
predominant, pathogenic anti-Dsg3 autoantibodies produced in the
PV model mouse were of the IgG1 type. IgG4 is predominant over
IgG in human PV (David et al, 1989; Yamada et al, 1989; Shirakata
Figure 4. Histopathologic comparisons of PV model and Dsg3±/±
mice. Histopathologic ®ndings in PV model mice (a, c, e, g, i, j) and
Dsg3±/± mice (b, d, f, h). Suprabasilar acantholysis was observed with
similar distribution on the traumatized skin (a, b, snout; c, d, ear; e, f,
paw) and mucous membranes (g, h: hard palate); however, involvement
of the esophagus and forestomach was observed only in PV model mice
(i, j). Mucosal epithelia were detached from the lamina propria mucosae
with in¯ammatory cell in®ltrations (i, esophagus). Acantholysis was
observed around the squamocolumnar junction (j, forestomach). Scale bar:
50 mm (hematoxylin and eosin staining).
Table I. Distribution of affected tissues with suprabasilar
acantholysis in PV model mice and Dsg3-/- mice in
histologya
Site PV model mouse (n = 15) Dsg3-/- mouse (n = 15)
Skin
snout 12 9
eyelid 7 7
ear 14 11
trunk 5 2
paw 12 7
tail 8 2
Squamous mucosa
tongue 7 5
buccal mucosa 2 2
palate 10 4
larynx 6 4
esophagus 3 0
forestomach 1 0
Lung 0 0
Liver 0 0
Stomach 0 0
Intestine 0 0
Kidney 0 0
aNumbers of mice with involvement at the designated tissue were indicated.
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et al, 1990; Dmochowski et al, 1992; Futei et al, 2001).
Interestingly, although there is no distinct correlation between
the human and mouse IgG subclasses, human IgG4 resembles
mouse IgG1 in its inability to ®x complement (BruÈggemann et al,
1987; Dangl et al, 1988). We are aware that the PV model does not
mimic the onset of human PV, because production of the
pathogenic anti-Dsg3 IgG is initiated by the adoptive transfer of
splenocytes from Dsg3±/± mice to Dsg3+/+ mice. The importance
of the noncomplement-®xing IgG subclasses, however, brings the
murine PV model closer to human PV in terms of events that occur
after antibody binding to Dsg3.
PV model mice were almost indistinguishable from Dsg3±/± mice
in gross as well as microscopic appearance. Both types of mouse
showed cell±cell adhesion loss, i.e., suprabasilar acantholysis, in the
strati®ed squamous epithelia, including the oral mucous membranes
and the skin where scratching or constant physical pressure
occurred (Table I, Figs 3 and 4); however, some PV model
mice demonstrated more severe phenotypes than the Dsg3±/± mice.
These PV model mice showed features such as heavily encrusted
erosions on the paws and elongated front teeth, which were rarely
found in Dsg3±/± mice. The involvement of the esophagus and
forestomach was found in some PV model mice, but not in Dsg3±/±
mice. To evaluate these subtle phenotypic differences in a
quantitative fashion, the number of affected sites with suprabasilar
acantholysis was counted under microscopy. Among the mice
tested, about 50% of the PV model mice (seven of 15) had more
lesions than any of the Dsg3±/± mice, indicating that some PV
model mice had more severe microscopic defects than the Dsg3±/±
mice. On the other hand, approximately 15±20% of the mice that
underwent adoptive transfer of immunized Dsg3±/± splenocytes did
not develop the PV phenotype, in spite of circulating anti-Dsg3
IgG, probably due to insuf®cient amounts of anti-Dsg3 IgG
(Amagai et al, 2000). Therefore, PV model mice show greater
variety in the extent of lesions than Dsg3±/± mice.
Why do PV model mice and Dsg3±/± mice show this subtle
phenotypic difference? Is this variation caused by differences in
their genetic backgrounds? In the adoptive transfer experiment, we
used Rag2±/± recipient mice that were backcrossed to B6.SJL-Ptprca
mice for 10 generations (Schulz et al, 1996). The Dsg3±/± mice had
a mixed genetic background of 129/SV(H-2b) and C57BL/6J(H-
2b) (Koch et al, 1997). If genetic background plays a part, it should
apply to both PV model and Dsg3±/± mice. The major difference
between PV model and Dsg3±/± mice is that Dsg3 function is
blocked by IgG antibodies in PV model mice, whereas Dsg3 is
genetically depleted in Dsg3±/± mice. Therefore, the overall
similarities between PV model mice and Dsg3±/± mice suggest
that acantholysis is caused in the PV model mice by direct
interference from anti-Dsg3 IgG antibodies. The differences
between PV model and Dsg3±/± mice, however, suggest that, in
addition to antibody±antigen interactions, another factor may play a
part in the clinical appearance of PV. In PV model mice, as in
patients with PV, anti-Dsg3 IgG binds to Dsg3 on keratinocyte cell
surfaces and remains associated for weeks, even in skin of normal
appearance. Therefore, it is possible that long-lasting antibody±
antigen interactions on keratinocytes might cause secondary
in¯ammatory reactions via signal transduction or cytokine release,
thus leading to phenotypic modi®cations. This type of reaction
cannot be studied with the previous passive-transfer model using
neonatal mice, because that model represents only the acute phase
of blister formation.
One of the characteristic histologic features of pemphigus is
eosinophilic spongiosis, a term coined by Emmerson and Wilson
Jones (1968). Eosinophilic spongiosis was regarded initially as one
of the speci®c traits of pemphigus (Knight et al, 1976; Pearson et al,
1980), but now it is accepted that this histologic reaction is not only
observed in pemphigus (and PV) but also in other autoimmune
blistering diseases, such as bullous pemphigoid (Crotty et al, 1983;
Nishioka et al, 1984; Machado-Pinto et al, 1996). Although this
histologic ®nding is well described in the literature, the
pathophysiologic signi®cance of eosinophilic spongiosis has re-
mained elusive. Recently, Th2 cytokines, such as interleukin-5,
and chemokines, such as RANTES or eotaxin, have been
implicated in cutaneous eosinophil in®ltration (Ying et al, 1995;
SchroÈder et al, 1996; Moine et al, 1999; Yawalkar et al, 1999), and
keratinocytes are able to produce such factors (Li et al, 1996;
Wakugawa et al, 2000). In addition, patients with bullous
pemphigoid may have elevated eosinophil chemoattractants in
their sera or bullous ¯uids, which may result in eosinophilia
(D'Auria et al, 1998; Rico et al, 1999; Shrikhande et al, 2000;
Figure 6. Eosinophilic spongiosis in PV model mice. Eosinophilic
cell in®ltrations in the intercellular space of the epidermis were found in
some spongiotic sites of PV model mice (a), but not in those of Dsg3±/±
mice (b). Arrows indicate eosinophils. Scale bar: 50 mm (Chromotrope 2R
and hematoxylin staining).
Figure 5. Affected sites in PV model and Dsg3±/± mice. The
number of affected sites per mouse was counted for PV model and
Dsg3±/± mice. Some PV model mice were more severely affected and
PV model mice showed broader variations in the extent of microscopic
lesions than Dsg3±/± mice. Bars indicate the mean values for each group.
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Wakugawa et al, 2000); however, no data supporting the involve-
ment of interleukin-5 or RANTES in eosinophilic in®ltrations in
PV have been reported to date (Bornscheuer et al, 1999; Rico et al,
1999). Eosinophilic spongiosis was demonstrated in PV model mice
with Chromotrope 2R staining, although no apparent eosinophilic
in®ltration was observed in Dsg3±/± mice. Therefore, the PV model
mouse provides a valuable tool to investigate unknown molecular
mechanisms in the formation of eosinophilic spongiosis and their
role in the pathogenesis of PV.
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